As per the collaboration, the parties will explore the use of both existing and proprietary delivery approaches for dermatological applications. Each party will contribute technology and resources to
As per the terms of the agreement, Pfizer is expected to provide an upfront payment, funding for the discovery and preclinical development of novel antibiotics to treat MDR-TB,
The System 1E is indicated for liquid chemical sterilization of cleaned, immersible, and reusable critical and semi-critical heat sensitive medical devices in healthcare facilities. Steris continues dialogue with
Seasonique is manufactured by Duramed Pharmaceuticals, a wholly owned subsidiary of Teva Pharmaceutical Industries. Under the Seasonique extended-cycle regimen, women take active tablets of 0.15mg levonorgestrel/0.03mg of ethinyl
Bolton Medical said that when a covered (or non-bare) stent is used in a tightly curved aorta, it can cause a gap or ‘bird beak’ in which the
The data analysis has confirmed that the trial has met its end points of demonstrating safety and tolerability. In addition, the treatment has shown proof of principle of
Cantox and Ashuren are global scientific research and regulatory consulting organisations providing solutions for clients in food and nutrition, agriculture, biotechnology, consumer products, chemicals, pharmaceuticals and healthcare. The
Through this agreement, Icon and Tigermed will collaborate to offer pharmaceutical and biotechnology clients better access to Chinese patients, utilising the global reach and experience of the Icon
Edoxaban, being developed solely by Daiichi Sankyo, is an oral anticoagulant that directly and specifically inhibits Factor Xa. Reportedly, the results from pivotal Phase III studies showed that
Pitavastatin is a new statin for the treatment of hypercholesterolemia. As per the agreement, Esteve is expected to co-market the product together with Recordati Espana, the Spanish subsidiary
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.